Lynn Kirkpatrick
CIK 1418785 · Chief Executive Officer · last filed 2022-05-27
Lynn Kirkpatrick is a Chief Executive Officer who has filed 5 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for ENSC, was dated May 27, 2022. Across all open-market trades the lifetime net is +$48.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $89.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$89.1K
2
5
$48.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENSC | Chief Executive Officer | 354,851 | $0.25 | $89.1K | $48.3K | 3 | 2022-05-27 |
| Cascadian Therapeutics, Inc. (ONTY) Delisted | Chief Scientific Officer | 1,613,872 | — | — | $0 | 2 | 2008-06-05 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-27 | ENSC | Mixed | +97,000 | $48.3K | EDGAR |
| 2022-02-24 | ENSC | Grant (A) | — | $0 | EDGAR |
| 2021-07-02 | ENSC | Grant (A) | +284,851 | $0 | EDGAR |
| 2008-06-05 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-12-12 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Other (J) | +1,613,872 | $0 | EDGAR |